JP Morgan Call 300 MKTX 16.08.202.../ DE000JB8UMH8 /
31/05/2024 12:07:31 | Diferencia-0.001 | Bid22:00:38 | Ask22:00:38 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.005EUR | -16.67% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
MarketAxess Holdings... | 300.00 USD | 16/08/2024 | Call |
GlobeNewswire
2:38
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
1:00
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página